EAST WINDSOR, N.J.--(BUSINESS WIRE)--NexMed, Inc. (Nasdaq: NEXM), a developer of innovative treatments based on the NexACT® technology, announced today that on October 9, 2008, it received a letter from The NASDAQ Listing Qualifications Department providing notification that, for the last 30 consecutive business days, the bid price of its common stock has closed below the minimum $1.00 per share requirement for continued inclusion on The NASDAQ Capital Market under NASDAQ Marketplace Rule 4310(c)(4) (the “Rule”). In accordance with NASDAQ Marketplace Rule 4310(8)(D), NexMed has 180 calendar days, or until April 7, 2009, to regain compliance with the Rule. NexMed can regain compliance with the Rule if at anytime before April 7, 2009, the bid price of its common stock closes at $1.00 per share or more for a minimum of 10 consecutive business days.
